secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001104659-25-104917
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq confirms Entero Therapeutics regains compliance with equity rule
-----------------------------------------------------------------------

- Nasdaq letter dated Oct 28, 2025 confirms company meets $2.5M minimum stockholders' equity requirement.
- Company previously reported negative equity of ($3.87M) in 10-K; received extension until Oct 8, 2025.
- Compliance achieved via share exchange with GridAI Corp, disclosed in Oct 6, 2025 8-K.
- Nasdaq warned that failure to maintain compliance in next periodic report may trigger delisting proceedings.
- Company's stock (ENTO) continues trading on Nasdaq Capital Market without immediate delisting risk.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925104917/0001104659-25-104917-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465925104917/tm2529898d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-104917

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer